approval · primary record
TRASTUZUMAB-ANNS
FDA · BLA · 2024-12-19
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2024-12-19 |
| Brand | KANJINTI |
| Sponsor | AMGEN INC |
| Route | SINGLE-DOSE |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:40:41.967Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:TRASTUZUMAB-ANNS:2024-12-19
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Trastuzumab-Anns · compound